DK1664770T3 - Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner - Google Patents
Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventionerInfo
- Publication number
- DK1664770T3 DK1664770T3 DK04774923T DK04774923T DK1664770T3 DK 1664770 T3 DK1664770 T3 DK 1664770T3 DK 04774923 T DK04774923 T DK 04774923T DK 04774923 T DK04774923 T DK 04774923T DK 1664770 T3 DK1664770 T3 DK 1664770T3
- Authority
- DK
- Denmark
- Prior art keywords
- disease
- biological profile
- impact
- determining
- group
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/60—ICT specially adapted for the handling or processing of medical references relating to pathologies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2550/00—Electrophoretic profiling, e.g. for proteome analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Databases & Information Systems (AREA)
- Data Mining & Analysis (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03077804A EP1512970A1 (de) | 2003-09-05 | 2003-09-05 | Verfahren zur Bestimmung der Wirkung einer Zusammensetzung auf das Profil einer Krankheit |
| PCT/NL2004/000617 WO2005024421A1 (en) | 2003-09-05 | 2004-09-03 | Method for determining the impact of a multicomponent synthetic product mixture on the biological profile of a disease within a group of living systems and the development of new combinatorial interventions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1664770T3 true DK1664770T3 (da) | 2008-03-25 |
Family
ID=34130247
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774923T DK1664770T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner |
| DK04774922T DK1664767T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04774922T DK1664767T3 (da) | 2003-09-05 | 2004-09-03 | Fremgangsmåde til bestemmelse af indvirkningen af en af flere komponenter bestående naturproduktblanding på den biologiske profil for en sygdom inden for en gruppe af levende systemer og udvikling og kvalitetskontrol af medicin baseret på naturprodukter |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20070020180A1 (de) |
| EP (3) | EP1512970A1 (de) |
| JP (2) | JP2007508603A (de) |
| CN (2) | CN1875273A (de) |
| AT (2) | ATE378593T1 (de) |
| DE (2) | DE602004010154T2 (de) |
| DK (2) | DK1664770T3 (de) |
| EA (1) | EA011959B1 (de) |
| ES (2) | ES2297475T3 (de) |
| WO (2) | WO2005024421A1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7425700B2 (en) | 2003-05-22 | 2008-09-16 | Stults John T | Systems and methods for discovery and analysis of markers |
| EP1512970A1 (de) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Verfahren zur Bestimmung der Wirkung einer Zusammensetzung auf das Profil einer Krankheit |
| US7729789B2 (en) * | 2004-05-04 | 2010-06-01 | Fisher-Rosemount Systems, Inc. | Process plant monitoring based on multivariate statistical analysis and on-line process simulation |
| US20080183101A1 (en) * | 2006-08-17 | 2008-07-31 | Jonathan Richard Stonehouse | Salivary analysis |
| KR101459805B1 (ko) | 2007-03-30 | 2014-11-07 | 9898 리미티드 | 천연 산물 개발을 위한 약제 플랫폼 기법 |
| DE102008011013B4 (de) * | 2008-02-25 | 2014-11-13 | Mevitec Gmbh | Verfahren und Einrichtung zur komplexen Stoffwechselanalyse |
| KR101144237B1 (ko) * | 2009-12-29 | 2012-05-11 | 한국기초과학지원연구원 | 고분해능 질량분석법과 약리활성검사를 이용한 천연물의 약리 활성물질 발굴 방법 |
| MY181093A (en) | 2011-03-02 | 2020-12-17 | Berg Llc | Interrogatory cell-based assays and uses thereof |
| MX357392B (es) * | 2012-04-02 | 2018-07-06 | Berg Llc | Ensayos basados en interrogatorios celulares y uso de los mismos. |
| JP2014020831A (ja) * | 2012-07-13 | 2014-02-03 | Kyoto Univ | 混合物試料の属性を識別する方法及び装置 |
| US20150019189A1 (en) * | 2013-07-01 | 2015-01-15 | Counterpoint Health Solutions, Inc. | Systems biology approach to therapy |
| WO2016039348A1 (ja) * | 2014-09-10 | 2016-03-17 | 一般財団法人ニッセンケン品質評価センター | タンパク質繊維の鑑別方法 |
| CN107111603A (zh) | 2014-09-11 | 2017-08-29 | 博格有限责任公司 | 基于患者数据的用于健康护理诊断和治疗的贝叶斯因果关系网络模型 |
| CN109115904B (zh) * | 2018-07-25 | 2021-02-02 | 山西广誉远国药有限公司 | 一种定坤丹uplc指纹图谱的构建方法及其应用 |
| CA3146525A1 (en) | 2019-08-05 | 2021-02-11 | William Manning | Systems and methods for sample preparation, data generation, and protein corona analysis |
| CN111180007A (zh) * | 2019-12-03 | 2020-05-19 | 深圳市开物成务中医药科技有限公司 | 一种安全、有效、高质量中药开发平台系统及实现方法 |
| CN111060640A (zh) * | 2019-12-27 | 2020-04-24 | 深圳市开物成务中医药科技有限公司 | 测定与胰岛素耐受性相关的血脂谱的方法、应用及装置 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5885782A (en) * | 1994-09-13 | 1999-03-23 | Nce Pharmaceuticals, Inc. | Synthetic antibiotics |
| US5563043A (en) * | 1994-10-24 | 1996-10-08 | Spiral Biotech, Inc. | Method for measuring the bactericidal and bacteriostatic effects of antimicrobial agents |
| US6379714B1 (en) * | 1995-04-14 | 2002-04-30 | Pharmaprint, Inc. | Pharmaceutical grade botanical drugs |
| WO1997020076A1 (en) * | 1995-11-29 | 1997-06-05 | Nexstar Pharmaceuticals, Inc. | Methods for optimizing multicomponent formulations |
| JP3978529B2 (ja) * | 1998-08-03 | 2007-09-19 | 大正製薬株式会社 | 冬虫夏草の判別法 |
| US20030044846A1 (en) * | 2001-04-03 | 2003-03-06 | Gary Eldridge | Screening of chemical compounds purified from biological sources |
| CA2373708A1 (en) * | 2000-03-09 | 2001-09-13 | Yale University | Phytomics: a genomic-based approach to herbal compositions |
| US20020095260A1 (en) * | 2000-11-28 | 2002-07-18 | Surromed, Inc. | Methods for efficiently mining broad data sets for biological markers |
| EP1425695A2 (de) * | 2001-08-13 | 2004-06-09 | Beyong Genomics, Inc. | Verfahren und system zum profilieren von biologischen systemen |
| TW573125B (en) * | 2001-08-29 | 2004-01-21 | Combinatorx Inc | A screening system for identifying drug-drug interactions and methods of use thereof |
| EP1512970A1 (de) * | 2003-09-05 | 2005-03-09 | Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO | Verfahren zur Bestimmung der Wirkung einer Zusammensetzung auf das Profil einer Krankheit |
| CN101268368A (zh) * | 2005-01-28 | 2008-09-17 | 儿童医疗中心有限公司 | 上皮癌的诊断和预后方法 |
-
2003
- 2003-09-05 EP EP03077804A patent/EP1512970A1/de not_active Withdrawn
-
2004
- 2004-09-03 CN CNA2004800324024A patent/CN1875273A/zh active Pending
- 2004-09-03 DE DE602004010154T patent/DE602004010154T2/de not_active Expired - Lifetime
- 2004-09-03 DK DK04774923T patent/DK1664770T3/da active
- 2004-09-03 AT AT04774922T patent/ATE378593T1/de active
- 2004-09-03 CN CNA2004800325525A patent/CN1875274A/zh active Pending
- 2004-09-03 US US10/570,505 patent/US20070020180A1/en not_active Abandoned
- 2004-09-03 EA EA200600539A patent/EA011959B1/ru not_active IP Right Cessation
- 2004-09-03 ES ES04774922T patent/ES2297475T3/es not_active Expired - Lifetime
- 2004-09-03 US US10/571,087 patent/US20070160990A1/en not_active Abandoned
- 2004-09-03 EP EP04774923A patent/EP1664770B1/de not_active Expired - Lifetime
- 2004-09-03 WO PCT/NL2004/000617 patent/WO2005024421A1/en active IP Right Grant
- 2004-09-03 WO PCT/NL2004/000616 patent/WO2005024420A1/en active IP Right Grant
- 2004-09-03 EP EP04774922A patent/EP1664767B1/de not_active Expired - Lifetime
- 2004-09-03 DK DK04774922T patent/DK1664767T3/da active
- 2004-09-03 AT AT04774923T patent/ATE378594T1/de active
- 2004-09-03 JP JP2006525292A patent/JP2007508603A/ja active Pending
- 2004-09-03 JP JP2006525291A patent/JP4675896B2/ja not_active Expired - Fee Related
- 2004-09-03 ES ES04774923T patent/ES2297476T3/es not_active Expired - Lifetime
- 2004-09-03 DE DE602004010155T patent/DE602004010155T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1664767B1 (de) | 2007-11-14 |
| US20070160990A1 (en) | 2007-07-12 |
| EA011959B1 (ru) | 2009-06-30 |
| JP4675896B2 (ja) | 2011-04-27 |
| ATE378593T1 (de) | 2007-11-15 |
| US20070020180A1 (en) | 2007-01-25 |
| EP1664770A1 (de) | 2006-06-07 |
| DK1664767T3 (da) | 2008-03-25 |
| DE602004010154D1 (de) | 2007-12-27 |
| JP2007508603A (ja) | 2007-04-05 |
| JP2007510132A (ja) | 2007-04-19 |
| DE602004010155T2 (de) | 2008-09-25 |
| DE602004010154T2 (de) | 2008-09-25 |
| WO2005024421A1 (en) | 2005-03-17 |
| WO2005024420A1 (en) | 2005-03-17 |
| ATE378594T1 (de) | 2007-11-15 |
| EP1664770B1 (de) | 2007-11-14 |
| DE602004010155D1 (de) | 2007-12-27 |
| CN1875273A (zh) | 2006-12-06 |
| EP1512970A1 (de) | 2005-03-09 |
| EA200600539A1 (ru) | 2006-08-25 |
| EP1664767A1 (de) | 2006-06-07 |
| CN1875274A (zh) | 2006-12-06 |
| ES2297476T3 (es) | 2008-05-01 |
| ES2297475T3 (es) | 2008-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1664770T3 (da) | Fremgangsmåde til bestemmelse af indvirkningen af en multikomponent-syntetisk-produkt-blanding på den biologiske profil for sygdom inden for en gruppe af levende systemer og udviklingen af nye kombinatoriske interventioner | |
| CY1111612T1 (el) | Μεθοδος για προβλεψη της αποκρισης σε μια θεραπευτικη αγωγη με εναν αναστολεαδιmερισmου του her | |
| CY1114701T1 (el) | Συνθεσεις και μεθοδοι για αυξηση ασβεστοποιησης οστων | |
| BRPI0618391A2 (pt) | método para identificar um nucleotìdeo individual, método para seqüenciar uma seqüência de ácido nucleico alvo, e, kit para seqüenciar um ácido nucleico | |
| WO2006062811A3 (en) | Method for measuring resistance or sensitivity to docetaxel | |
| DE602006017365D1 (de) | Zusammensetzungen für die identifizierung von adenoviren | |
| ATE419388T1 (de) | Nukleinsäureanreicherung | |
| BR0311823B1 (pt) | mÉtodo de determinaÇço de pelo menos um parÂmetro de formaÇço de interesse. | |
| ATE488251T1 (de) | Verfahren zur diagnose und behandlung von schwangerschaftsskomplikationen | |
| ATE507224T1 (de) | Verfahren und zwischenverbindungen zur herstellung von n4-phenyl-quinazolin-4-amin derivaten | |
| DE602006021223D1 (de) | Verfahren zur identifizierung von trpv2-modulatoren | |
| EA200901436A1 (ru) | Антигенсвязывающие белки, связывающие par-2 | |
| WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
| DE602005012405D1 (de) | Verfahren zur chiralen inversion von (s)-(+)- und (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepin-5-carbonsäureamid und optisch angereicherten mischungen davon | |
| ATE432997T1 (de) | Therapieüberwachung für tumoren unter benutzung acc133 mrna | |
| DK1604203T3 (da) | Fremgangsmåde til direkte bestemmelse af individuelle methotrexatmeta-bolitter | |
| DK1692181T3 (da) | Leptinantagonist og fremgangsmåde til kvantitativ måling af leptin | |
| DE602005016650D1 (de) | Methoden und system zur identifikation und charakterisierung von peptiden und ihrer funktionellen beziehung mittels berechnung von korrelation | |
| WO2007024825A3 (en) | Immunoaffinity separation and analysis compositions and methods | |
| ATE446299T1 (de) | Verfahren zur herstellung von 7-ethyl-10- hydroxycamptothecin | |
| DE602005017127D1 (de) | Rung und identifizierung von flüssigkeiten | |
| DE602004009243D1 (de) | Verfahren zur den Stoffwechsel betreffenden Führung von eingeleitetem zellulärem Material | |
| DK1664793T3 (da) | Neurotoksisk aminosyre eller neurotoksisk derivat deraf forbundet med neurologiske lidelser | |
| BRPI0414365A (pt) | composições, reagentes e kits para, e métodos de diagnosticar, monitorar e tratar obesidade e/ou diabetes | |
| ATE414701T1 (de) | Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren |